Showing results (1-10 of 169) with videos related to
Sort By:
Pageof 17
Current Opinion in Critical Care|August 7, 2010
Cardiovascular complications of AIDSJohn Lekakis, Ignatios IkonomidisHellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 23, 2016
PCSK9 inhibition as an emerging lipid lowering therapy: Unanswered questionsLοukianos S Rallidis, John LekakisCardiovascular Drugs and Therapy|June 24, 2017
Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading RoleDimitrios Alexopoulos, Panagiotis Vlachakis, John LekakisCurrent Opinion in Cardiology|June 8, 2015
Arterial stiffness and coronary artery diseaseIgnatios Ikonomidis, George Makavos, John LekakisJournal of Cardiovascular Pharmacology and Therapeutics|December 13, 2017
Cangrelor in Percutaneous Coronary Intervention: Current Status and PerspectivesDimitrios Alexopoulos, Christos Pappas, Danai Sfantou, et al.European Journal of Heart Failure|December 22, 2016
Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and managementDimitrios Farmakis, Filippos Triposkiadis, John Lekakis, et al.International Journal of Cardiology|April 3, 2007
Current questions regarding the use of statins in patients with coronary heart diseaseLoukianos S Rallidis, John Lekakis, Dimitrios T KremastinosBMC Medicine|April 8, 2015
Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practiceGerasimos Filippatos, Dimitrios Farmakis, John Parissis, et al.Platelets|October 13, 2017
Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?Dimitrios Alexopoulos, Konstantinos Katogiannis, Danai Sfantou, et al.Journal of the American College of Cardiology|September 10, 2016
Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients: Facing a New Trilemma?Dimitrios Alexopoulos, Ioanna Xanthopoulou, Athanasios Moulias, et al.Pageof 17